Episode #3: The new GLP-1 kid on the block - Semaglutide!

Episode #3: The new GLP-1 kid on the block - Semaglutide!

Disgruntled Dan's Pharmacy Podcast

Share Podcast:
Disgruntled Dan’s Conclusions: Semaglutide reduces the risk of nonfatal stroke (NNT 97 for 2.1 years), new or worsening nephropathy (NNT 43 over 2.1 years), and revascularization. Yes – there was a reduction in the composite MACE outcomes, but this was primarily driven by the results from nonfatal strokes. Use with caution in patients that currently have retinopathies – Semaglutide may worsen and/or cause retinopathies and the exact cause is curr...Read More
Disgruntled Dan’s Conclusions: Semaglutide reduces the risk of nonfatal stroke (NNT 97 for...Read More